HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

MLN 9708

a proteasome inhibitor with antineoplastic activity; structure in first source
Also Known As:
MLN-9708; MLN9708
Networked: 7 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Anderson, Kenneth C: 3 articles (03/2015 - 08/2011)
2. Chauhan, Dharminder: 3 articles (03/2014 - 08/2011)
3. Tian, Ze: 3 articles (03/2014 - 08/2011)
4. Berger, Allison J: 3 articles (03/2014 - 12/2011)
5. Raje, Noopur: 2 articles (03/2014 - 08/2011)
6. Richardson, Paul: 2 articles (11/2012 - 08/2011)
7. Fitzgerald, Michael: 2 articles (12/2011 - 03/2010)
8. Kupperman, Erik: 2 articles (12/2011 - 03/2010)
9. Manfredi, Mark: 2 articles (12/2011 - 03/2010)
10. Bannerman, Bret: 2 articles (12/2011 - 03/2010)

Related Diseases

1. Neoplasms (Cancer)
2. Sickle Cell Anemia (Hemoglobin S Disease)
3. Hematologic Neoplasms (Hematological Malignancy)
4. Multiple Myeloma
5. Lymphoma (Lymphomas)

Related Drugs and Biologics

1. Proteasome Endopeptidase Complex (Proteasome)
2. bortezomib (Velcade)
3. Citric Acid (Citrate)
4. carfilzomib
5. ATP dependent 26S protease (26S proteasome)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)